Prostate Cancer - Results from #1160

A Systematic Review and Meta-analysis of the Impact of Local Therapies on Local Event Suppression in Metastatic Hormone-sensitive Prostate Cancer. April 8, 2024

Prostate cancer detection and complications of MRI-targeted prostate biopsy using cognitive registration, software-assisted image fusion or in-bore guidance: a systematic review and meta-analysis of comparative studies. April 8, 2024

Clinical Outcomes of Combined Prostate- and Metastasis-Directed Radiation Therapy for the Treatment of De Novo Oligometastatic Prostate Cancer. April 8, 2024

Multidisciplinary total eradication therapy (TET) in men with newly diagnosed oligometastatic prostate cancer. April 8, 2024

Complications Following Transrectal and Transperineal Prostate Biopsy: Results of the ProBE-PC Randomized Clinical Trial. April 8, 2024

Europa Uomo Patient Reported Outcome Study (EUPROMS): Descriptive Statistics of a Prostate Cancer Survey from Patients for Patients. April 8, 2024

Treatment patterns and outcomes in metastatic castration-resistant prostate cancer patients with and without somatic or germline alterations in homologous recombination repair genes. April 8, 2024

Mortality Risks Associated with Depression in Men with Prostate Cancer. April 8, 2024

Repeat Next-Generation Sequencing Testing on Progression in Men With Metastatic Prostate Cancer Can Identify New Actionable Alterations. April 8, 2024

Novartis Confirms Plans to File for Pluvicto® Pre-Taxane Label Expansion in H2 2024 Based on Latest Data from Phase III PSMAfore Study April 5, 2024

Emerging racial disparities among Medicare beneficiaries and Veterans with metastatic castration-sensitive prostate cancer. April 5, 2024

Variation in management of lymph node positive prostate cancer after radical prostatectomy within a statewide quality improvement consortium. April 5, 2024

Multi-institutional Analysis of Metastasis-directed Therapy with or Without Androgen Deprivation Therapy in Oligometastatic Castration-sensitive Prostate Cancer. April 5, 2024

Prostate Radiotherapy in Low-volume Metastatic Hormone-sensitive Prostate Cancer: A Network Meta-analysis. April 5, 2024

Research Protocol for an Observational Health Data Analysis on the Adverse Events of Systemic Treatment in Patients with Metastatic Hormone-sensitive Prostate Cancer: Big Data Analytics Using the PIONEER Platform. April 5, 2024

Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomised Clinical Tria April 5, 2024

A Single-Institution Prospective Study To Evaluate the Safety and Efficacy of Real- Time Image-Gated Spot-Scanning Proton Therapy (RGPT) for Prostate Cancer. April 4, 2024

Pretreatment Patient-reported Overall Health: A Prognostic Factor for Early Overall Mortality After Primary Curative Treatment of Prostate Cancer. April 4, 2024

Combination of prostate volume and apparent diffusion coefficient can stratify patients with a PI-RADS score of 3 to reduce unnecessary prostate biopsies. April 4, 2024

Adequacy of prostate cancer prevention and screening recommendations provided by an artificial intelligence-powered large language model. April 4, 2024

Page 59 of 1438